XPD common variants and their association with melanoma and breast cancer risk

Breast Cancer Research and Treatment

Volumn 98, Issue 2, 2006, Pages 209-215

  Debniak T ^a   Scott, R J ^b   Huzarski, T ^a   Byrski, T ^a   Masojc B ^a   Van De Wetering, T ^a   Serrano Fernandez, P ^a   Gorski B ^a   Cybulski, C ^a   Gronwald, J ^a   Debniak B ^c   Maleszka, R ^a   Kladny J ^a   Bieniek, A ^d   Nagay, L ^e   Haus, O ^f   Grzybowska, E ^g   Wandzel, P ^h   Niepsuj, S ⁱ   Narod, S A ^j   Lubinski, J ^a   more..

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c Regional Hospital   (Poland)

^d WROCLAW MEDICAL UNIVERSITY   (Poland)

^e Regional Hospital   (Poland)

^f NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^g INSTITUTE OF ONCOLOGY   (Poland)

^h Regional Hospital Bielsko Bia a   (Poland)

ⁱ Regional Oncology Hospital   (Poland)

^j UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

Breast cancer; Malignant melanoma; XPD variants

Indexed keywords

ARGININE; ASPARTIC ACID; GLUTAMINE; GLYCINE; HISTIDINE; LEUCINE; LYSINE; PROLINE; PROTEIN; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHY; HAPLOTYPE; HEREDITY; HUMAN; MALE; MELANOMA; NEWBORN; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MELANOMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 33745919537     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9151-2     Document Type: Article

References (26)

1. Goldstein AM, Tucker MA: Genetic epidemiology of familial melanoma. Dermatol Clin 13: 605-612, 1995
2. Greene MH: The genetics of hereditary melanoma and nevi. 1998 update. Cancer 86: 2464-2477, 1999
3. Tsao H: Update on familial cancer syndromes and the skin. J Am Acad Dermatol 42: 939-970, 2000
4. Cleaver JE, Thompson LH, Richardson AS, States JC: A summary of mutations in the UV-sensitive disorders: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. Hum Mutat 14: 9-22, 1999
5. Berneburg M, Lehmann AR: Xeroderma pigmentosum and related disorders: defects in DNA repair and transcription. Adv Genet 43: 71-102, 2001
6. Broughton BC, Steingrimsdottir H, Weber CA, Lehmann AR: Mutations in the xeroderma pigmentosum group D DNA repair/transcription gene in patients with trichothiodystrophy. Nat Genet 7: 189-194, 1994
7. Tomescu D, Kavanagh G, Ha T, Campbell H, Melton DW: Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma. Carcinogenesis 22: 403-408, 2001
8. Winsey SL, Haldar NA, Marsh HP, et al.: A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 60: 5612-5616, 2000
9. Han J, Colditz GA, Liu JS, Hunter DJ: Genetic variation in XPD, sun exposure, and risk of skin cancer. Cancer Epidemiol Biomarkers Prev 14: 1539-1544, 2005
10. Baccarelli A, Calista D, Minghetti P, et al.: XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk. Br J Cancer 90: 497-502, 2004
11. Justenhoven C, Hamann U, Pesch B, et al.: ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol Biomarkers Prev 13: 2059-2064, 2004
12. Zhang L, Zhang Z, Yan W: Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clin Chim Acta 359: 150-155, 2005
13. Forsti A, Angelini S, Festa F, et al.: Single nucleotide polymorphisms in breast cancer. Oncol Rep 11: 917-922, 2004
14. Ott J: Utility programs for analysis of genetic linkage; Program HWE, URL: http://www.hgmp.mrc.ac.uk/Registered/Help/link-util/, 1988
15. Ding K, Zhou K, He F, Shen Y: LDA - A java-based linkage disequilibrium analyzer. Bioinformatics 19: 2147-2148, 2003
16. Coin F, Marinoni JC, Rodolfo C, Fribourg S, Pedrini AM, Egly JM: Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nat Genet 20: 184-188, 1998
17. Benhamou S, Sarasin A: ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis 17: 463-469, 2002
18. Gorski B, Jakubowska A, Huzarski T, et al.: A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 110: 683-686, 2004
19. Cybulski C, Huzarski T, Gorski B, et al.: A novel founder CHEK2 mutation is associated with increased prostate cancer risk. Cancer Res 64: 2677-2679, 2004
20. Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hansson J: CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas. Cancer Res 60: 6864-6867, 2000
21. Debniak T, Scott RJ, Huzarski T, et al.: CDKN2A common variants and their association with melanoma risk: a population-based study. Cancer Res 65: -835-839, 2005
22. Debniak T, Gorski B, Huzarski T, et al.: A common variant of CDKN2A (p16) predisposes to breast cancer. J Med Genet, 2005 (in press)
23. Schabath MB, Delclos GL, Grossman HB, et al.: Polymorphisms in XPD exons 10 and 23 and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 14: 878-884, 2005
24. Brewster AM, Alberg AJ, Strickland PT, Hoffman SC, Helzlsouer K: XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 13: 1271-1275, 2004
25. Lovatt T, Alldersea J, Lear JT, et al.: Polymorphism in the nuclear excision repair gene ERCC2/XPD: association between an exon 6-exon 10 haplotype and susceptibility to cutaneous basal cell carcinoma. Hum Mutat 25: 353-359, 2005
26. Yin J, Li J, Ma Y, Guo L, Wang H, Vogel U: The DNA repair gene ERCC2/XPD polymorphism Arg 156Arg (A22541C) and risk of lung cancer in a Chinese population. Cancer Lett 223: 219-226, 2005